Axonics® to Report First Quarter 2021 Financial Results on May 6, 2021
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that has developed and is commercializing novel products for...
Month: April 2021
Lighting It Up: CLS Holdings USA, Inc. Reports Third Quarter Results as Las Vegas Makes a Comeback
LAS VEGAS, NV / ACCESSWIRE / April 15, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a...
Relief Reports 2020 Financial Results and Provides Business Update
GENEVA, SWITZERLAND / ACCESSWIRE / April 15, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical...
Core One Labs to Rescind Share Exchange with Plant-Based Investment Corp.
VANCOUVER, BC / ACCESSWIRE / April 14, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(FRA:LD62)(WKN:A2P8K3) (the "Company" or "Core One")...
Radiko Announces Delayed Filing of Annual Financials and MD&A and Application for Management Cease Trade Order
LOS ANGELES, CA / ACCESSWIRE / April 14, 2021 / Radiko Holdings Corp. (CSE:RDKO) (the "Company") would like to provide...
Glaukos Corporation to Release First Quarter 2021 Financial Results after Market Close on May 5
Conference Call and Webcast Scheduled for 1:30 p.m. PDT SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology...
Novo Integrated Sciences Announces Second Quarter 2021 Financial Results
BELLEVUE, Wash.--(BUSINESS WIRE)--$NVOS--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo Integrated Sciences”), a provider of multidisciplinary primary healthcare, today...
Masimo to Report First Quarter 2021 Financial Results after Market Close on Tuesday, April 27
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release...
Cloud DX Announces Commencement of Trading on the Toronto Venture Exchange
TORONTO, ON / ACCESSWIRE / April 14, 2021 / Cloud DX Inc. (TSXV:CDX) ("Cloud DX" or the "Company") is pleased...
Neutra Now on Zoovu Platform, Giving VIVIS New Way to Reach Potential CBD Customers
KATY, TX / ACCESSWIRE / April 14, 2021 / Neutra Corp. (OTC PINK:NTRR) has been listed on the Zoovu platform,...
MitoChem Therapeutics Granted FDA Orphan Drug Designation for Treatment of Retinitis Pigmentosa
CHARLESTON, SC / ACCESSWIRE / April 14, 2021 / MitoChem Therapeutics, Inc., a privately held company developing therapies for diseases involving...
MediXall Group Reports Skyrocketed Conversion Rates for Health Karma Social Media Campaigns
Conversion rates more than double industry standards. FORT LAUDERDALE, FL / ACCESSWIRE / April 14, 2021 / MediXall Group, Inc....
Animal Model Market Driven by Developments in Pharmaceutical and CRISPR Genetic Research, Opines Fact.MR
Leading research organizations are investing increasingly in the use of advanced animal models for CRISPR and microinjection applications for long-term...
Jaguar Health and Napo Pharmaceuticals Announce Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Annual Meeting
SAN FRANCISCO, CA / ACCESSWIRE / April 14, 2021 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that an abstract associated...
Genome Protection Announces Publication of the Next Generation Deimmunized TLR5 Agonist, GP532
The substantially improved pharmacological profile of GP532 opens new opportunities for broader therapeutic applications of this class of pharmaceuticals BUFFALO,...
Biotricity to Report Record Revenue Results for Fiscal 2021
Unaudited Financial Results Include Revenue Growth of 133% REDWOOD CITY, CA / ACCESSWIRE / April 14, 2021 / Biotricity, Inc....
Intellipharmaceutics Announces First Quarter 2021 Results
TORONTO, ON / ACCESSWIRE / April 14, 2021 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing...
Alimera Sciences Receives $20 Million From Ocumension Therapeutics
Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to $89 million in additional sales-based...
Medicenna to Present at the Bloom Burton & Co. Healthcare Investor Conference
TORONTO and HOUSTON, April 14, 2021 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or “the Company") (NASDAQ: MDNA TSX: MDNA),...
Jushi Holdings Inc. Announces Purchase of Dalitso LLC Facility and Land in Prince William County, VA
Acquisition includes Dalitso’s 93,000 sq. ft. Facility and Nine Acres of Land Positioned to Efficiently Produce a Consistent Supply of...